Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo

Molecular Therapy(2022)10.1016/j.ymthe.2022.06.018Source: DataRank Database

Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo is a research paper published in Molecular Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 2.08)OA: hybridTopics (70)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Michael K Fink,Duraisamy Kempuraj ORCID,Nishant R. Sinha ORCID,Lynn M. Martin ORCID,Landon M. Keele

Live enrichment

PubMed:35780298 PMC:PMC9552811 OpenAlex:https://openalex.org/W4283771154

NEI

Grant: 5R01EY030774

NEI

Grant: 1 U01EY031650

NEI

Grant: /NEI 5R01EY017294

BLRD VA

Grant: I01 BX000357

BLRD VA

Grant: IK6 BX005646

NEI NIH HHS

Grant: R01 EY030774

NEI NIH HHS

Grant: U01 EY031650

NEI NIH HHS

Grant: R01 EY017294

National Institutes of Health

Grant: 2I01BX000357-08

Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases

National Institutes of Health

Grant: 5U01EY031650-02

Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard

National Institutes of Health

Grant: 3R01EY017294-03S2

Gene therapy in the cornea

FWCI

2.08

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ymthe.2022.06.018

HYBRIDhttps://doi.org/10.1016/j.ymthe.2022.06.018

publisherhttps://doi.org/10.1016/j.ymthe.2022.06.018

publisherhttps://api.elsevier.com/content/article/PII:S1525001622004191?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001622004191?httpAccept=text/plain

Fields of Study

Corneal Surgery and TreatmentsCorneal surgery and disordersOcular Surface and Contact LensMedicine0303 health sciences03 medical and health sciencesActinsAlkaliesAnimalsCicatrixCorneaCorneal DiseasesCorneal InjuriesCorneal OpacityDependovirusFibronectinsFibrosisGenetic TherapyRNA, MessengerRabbitsTransforming Growth FactorsAdeno-associated virus-5

MeSH Terms

ActinsDependovirusAlkaliesAnimalsCicatrixCorneaCorneal DiseasesCorneal OpacityFibronectinsFibrosisRabbitsRNA, MessengerTransforming Growth FactorsGenetic TherapyCorneal Injuries

Keywords

In vivoGenetic enhancementMyofibroblastMolecular biologyFibrosisPathologyImmunologyBiologyMedicineGeneBiochemistryGeneticsGene therapyHelix-loop-helixAlkali InjuryId3Corneal FibrosisAav5Inhibitor Of Differentiation 3Genetic TherapyAlkaliesDependovirusActinsCorneal DiseasesFibronectinsCorneaCicatrixCorneal OpacityTransforming Growth FactorsAnimalsRNA, MessengerRabbitsCorneal Injuries

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being